Yask Gupta

Ratzeburger Allee 160
Luebeck, SH 23562, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant.

Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant.

Journal: JAMA network open

Published: March 11, 2026

Corrigendum to CERT1 mutations perturb human development by disrupting sphingolipid homeostasis.

Corrigendum to CERT1 mutations perturb human development by disrupting sphingolipid homeostasis.

Journal: The Journal of clinical investigation

Published: November 03, 2025

Urobiota analysis and genome-wide association study in pediatric recurrent urinary tract infections and vesicoureteral reflux.

Urobiota analysis and genome-wide association study in pediatric recurrent urinary tract infections and vesicoureteral reflux.

Journal: JCI insight

Published: September 02, 2025

The APOL1 p.N264K variant is co-inherited with the G2 kidney disease risk variant through a proximity recombination event.

The APOL1 p.N264K variant is co-inherited with the G2 kidney disease risk variant through a proximity recombination event.

Journal: G3 (Bethesda, Md.)

Published: September 25, 2024

APOL1 Genotyping Is Incomplete without Testing for the Protective M1 Modifier p.N264K Variant.

APOL1 Genotyping Is Incomplete without Testing for the Protective M1 Modifier p.N264K Variant.

Journal: Glomerular diseases

Published: January 29, 2024

High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responses.

High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responses.

Journal: Journal of autoimmunity

Published: December 06, 2023

Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.

Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.

Journal: Nature communications

Published: August 25, 2023

Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.

Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.

Journal: medRxiv : the preprint server for health sciences

Published: August 14, 2023

Mouse and human studies support DSTYK loss of function as a low-penetrance and variable expressivity risk factor for congenital urinary tract anomalies.

Mouse and human studies support DSTYK loss of function as a low-penetrance and variable expressivity risk factor for congenital urinary tract anomalies.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: July 11, 2023

Impact of diet and host genetics on the murine intestinal mycobiome.

Impact of diet and host genetics on the murine intestinal mycobiome.

Journal: Nature communications

Published: September 20, 2022

Forward genetics and functional analysis highlight Itga11 as a modulator of murine psoriasiform dermatitis.

Forward genetics and functional analysis highlight Itga11 as a modulator of murine psoriasiform dermatitis.

Journal: The Journal of pathology

Published: September 15, 2022

Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndrome.

Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndrome.

Journal: Nature communications

Published: September 15, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026